Trials / Unknown
UnknownNCT04276623
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study on ophthalmological comorbidities and the underlying pathomechanisms of conjunctivitis during dupilumab treatment in atopic dermatitis (AD) patients. Patients participate in the Bioday Registry.
Conditions
Timeline
- Start date
- 2020-02-25
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2020-02-19
- Last updated
- 2023-11-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04276623. Inclusion in this directory is not an endorsement.